David S Shulman

24PUBLICATIONS
74CO-AUTHORS
Environmental epidemiologyMolecular targetsAdolescent healthHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 02, 2026
Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

|May 26, 2026
A first-in-pediatric study of ALRN-6924, a novel stapled-peptide dual MDM2/MDMX inhibitor, for children with advanced hematologic and solid malignancies.

|May 14, 2026
Clinical Liquid Biopsy Testing for Detection of Actionable Genomic Alterations in Children and Young Adults With Advanced Solid Tumors on the GAIN Study.

|Jan 12, 2026
Treatment and Outcomes of Children and Adults With Rhabdomyosarcoma in Rwanda.

Oscar Nsanzimana, Kendall Carpenter, Chandler Villaverde

|Nov 27, 2025
A Phase 1 Trial of Fimepinostat in Children and Adolescents With Relapsed and Refractory Solid and CNS Tumors.

David S Shulman, Kieuhoa T Vo, Frank M Balis

|Jun 24, 2025
Effect of HLA restriction on racial and ethnic disparities in access to immune therapies for advanced synovial sarcoma.

Vinayak Venkataraman, Hannah R Abrams, David S Shulman

Pageof 4

Frequent Collaborators

17 joint publications

Steven G DuBois

5 joint publications

Brian D Crompton

5 joint publications

Katherine A Janeway

4 joint publications

Allison F O'Neill